| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Madrigal Pharmaceuticals, Inc. (MDGL) have been net sellers, shedding 12,247 shares worth roughly $6.6M on balance.
MDGL sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.95M | - | - | |
| Dir | 452.7K | - | - | |
| CEO | 197.7K | $108.04M | - | |
| Dir | 187.2K | $99.04M | - | |
| Dir | 22.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Kelley Shannon T | General Counsel | Sell | 360 | $431.94 | $155,498.40 | -2.9% | +13.7% | - | |
| Mar 2, 2026 | Dier Mardi70 | EVP and CFO | Sell | 1,183 | $427.21 | $505,389.43 | -11.3% | +10.5% | - | |
| Jan 26, 2026 | Huntsman Carole | Chief Commercial Officer | Sell10b5-1 | 910 | $493.78 | $449,339.10 | -9.1% | +4.2% | - | |
| Jan 26, 2026 | Sibold William John | President and CEO | Sell | 1,577 | $492.42 | $776,546.34 | -1.1% | +4.2% | - | |
| Jan 26, 2026 | Taub Rebecca | Director | Sell | 647 | $492.42 | $318,595.74 | -0.1% | +4.2% | - | |
| Jan 20, 2026 | Kelley Shannon T | General Counsel | Sell10b5-1 | 692 | $497.36 | $344,173.11 | -7.5% | +4.4% | - | |
| Jan 20, 2026 | Taub Rebecca | Director | Sell | 2,238 | $490.77 | $1,098,343.26 | -0.5% | +4.4% | - | |
| Jan 9, 2026 | Taub Rebecca | Director | Sale+OE10b5-1 | 18,410 | $522.40 | $9,617,312.08 | -3.9% | +2.0% | - | |
| Jan 9, 2026 | Friedman Paul A | Director | Sale+OE10b5-1 | 24,520 | $522.39 | $12,808,956.93 | -11.6% | +2.0% | - | |
| Jan 9, 2026 | Taub Rebecca | Director | Sale+OE10b5-1 | 240 | $550.33 | $132,080.00 | - | +2.0% | - |